Liquidia Technologies Inc(LQDA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LQDA Liquidia Technologies Inc

盘前交易 12-24 07:47:41 EST

11.44

+0.34

+3.06%

盘前11.06

-0.38-3.32%

07:21 EST

最高11.47	最低10.96	成交量65.44万
今开11.13	昨收11.10	日振幅4.59%
总市值9.68亿	流通市值6.08亿	总股本8,464万
成交额741.35万	换手率1.23%	流通股本5,317万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"LQDA","market":"US","secType":"STK","nameCN":"Liquidia Technologies Inc","latestPrice":11.44,"timestamp":1734987600000,"preClose":11.1,"halted":0,"volume":654413,"hourTrading":{"tag":"盘前","latestPrice":11.06,"preClose":11.44,"latestTime":"07:21 EST","volume":1,"amount":11.06,"timestamp":1735042913123},"delay":0,"floatShares":53165432,"shares":84636621,"eps":-1.617348,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.34,"latestTime":"12-24 07:47:41 EST","open":11.13,"high":11.47,"low":10.96,"amount":7413520.942565,"amplitude":0.045946,"askPrice":11.8,"askSize":30,"bidPrice":9.52,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.617348,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735050600000},"adr":0,"listingDate":1532577600000,"adjPreClose":11.44,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":11.06,"preClose":11.44,"latestTime":"07:21 EST","volume":1,"amount":11.06,"timestamp":1735042913123},"postHourTrading":{"tag":"盘后","latestPrice":11.44,"preClose":11.44,"latestTime":"18:21 EST","volume":32425,"amount":370940.25,"timestamp":1734996115539},"volumeRatio":0.6443034915834169,"impliedVol":0.2627,"impliedVolPercentile":0.0478},"requestUrl":"/m/hq/s/LQDA","defaultTab":"news","newsList":[{"id":"2493421364","title":"Liquidia Corporation盘中异动 股价大涨5.00%报11.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493421364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493421364?lang=zh_cn&edition=full","pubTime":"2024-12-21 01:15","pubTimestamp":1734714941,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日01时15分，Liquidia Corporation股票出现波动，股价大幅上涨5.00%。截至发稿，该股报11.12美元/股，成交量24.422万股，换手率0.29%，振幅5.48%。Liquidia Corporation股票所在的生物技术行业中，整体涨幅为0.75%。Liquidia Corporation公司简介：Liquidia Corp 是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足未满足的患者需求，目前的重点是肺动脉高压  和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221011542a1fe6c9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221011542a1fe6c9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0208291251.USD","PH","LU1989772840.SGD","LU0320765489.SGD","BK4585","BK4588","LU0070302665.USD","LU0417517546.SGD","LU1989772923.USD","BK4161","LU0211331839.USD","LU0256863811.USD","LQDA","BK4007","LU0256863902.USD","BK4580"],"gpt_icon":0},{"id":"2492313049","title":"Liquidia Corporation盘中异动 大幅下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492313049","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492313049?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:29","pubTimestamp":1734550141,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日03时29分，Liquidia Corporation股票出现异动，股价急速下挫5.04%。Liquidia Corporation股票所在的生物技术行业中，整体跌幅为1.56%。Liquidia Corporation公司简介：Liquidia Corp 是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足未满足的患者需求，目前的重点是肺动脉高压  和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219032902a1f93d2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219032902a1f93d2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU0256863811.USD","LU0211331839.USD","PH","LU1989772923.USD","BK4161","LU0208291251.USD","LU0417517546.SGD","LU0320765489.SGD","BK4585","LU1989772840.SGD","CGTX","LQDA","BK4580","LU0070302665.USD","LU0256863902.USD","BK4007"],"gpt_icon":0},{"id":"2489231760","title":"Liquidia Corporation盘中异动 急速下跌5.23%报10.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489231760","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489231760?lang=zh_cn&edition=full","pubTime":"2024-12-06 22:57","pubTimestamp":1733497023,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日22时57分，Liquidia Corporation股票出现异动，股价急速下挫5.23%。截至发稿，该股报10.88美元/股，成交量11.2178万股，换手率0.13%，振幅5.40%。Liquidia Corporation股票所在的生物技术行业中，整体涨幅为0.34%。Liquidia Corporation公司简介：Liquidia Corp 是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足未满足的患者需求，目前的重点是肺动脉高压  和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206225703a1d97c7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206225703a1d97c7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU0256863811.USD","LU0211331839.USD","PH","LU1989772923.USD","BK4161","LU0208291251.USD","LU0417517546.SGD","LU0320765489.SGD","BK4585","LU1989772840.SGD","LQDA","BK4580","LU0070302665.USD","LU0256863902.USD","BK4007"],"gpt_icon":0},{"id":"2489852494","title":"Liquidia Corporation盘中异动 急速上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489852494","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489852494?lang=zh_cn&edition=full","pubTime":"2024-12-06 03:21","pubTimestamp":1733426472,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日03时21分，Liquidia Corporation股票出现异动，股价急速上涨5.05%。Liquidia Corporation股票所在的生物技术行业中，整体涨幅为0.15%。Liquidia Corporation公司简介：Liquidia Corp 是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足未满足的患者需求，目前的重点是肺动脉高压  和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120603211398e5a9f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120603211398e5a9f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0211331839.USD","BK4585","LU0256863902.USD","PH","LU0208291251.USD","LU0417517546.SGD","BK4007","LU0320765489.SGD","BK4161","LU1989772923.USD","LU1989772840.SGD","LU0070302665.USD","LQDA","BK4580","BK4588","LU0256863811.USD"],"gpt_icon":0},{"id":"1156261323","title":"异动解读 | Liquidia Corporation盘中股价大涨5.31%,生物制药公司业绩向好有望促进实现增长目标","url":"https://stock-news.laohu8.com/highlight/detail?id=1156261323","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156261323?lang=zh_cn&edition=full","pubTime":"2024-11-26 00:46","pubTimestamp":1732553185,"startTime":"0","endTime":"0","summary":"Liquidia Corporation今日盘中股价大涨5.31%,引发市场广泛关注。这家生物制药公司最新财报数据显示,营收同比实现大幅增长,业绩向好有望推动公司实现其发展目标。分析人士认为,Liquidia Corporation凭借其创新的PRINT技术平台,专注于开发制造创新药物,满足未满足的患者需求。在国内外监管机构的认可下,该产品有望获批上市并为公司带来丰厚收益。此外,机构投资者对Liquidia Corporation前景保持乐观,大部分券商给予买入评级。随着创新管线持续推进,这家生物技术公司有望成为行业新星。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Liquidia Corporation盘中股价大涨5.31%,生物制药公司业绩向好有望促进实现增长目标","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["LQDA"],"gpt_icon":0},{"id":"2486032188","title":"Liquidia Corporation盘中异动 临近午盘股价大涨5.07%报11.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486032188","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486032188?lang=zh_cn&edition=full","pubTime":"2024-11-26 00:37","pubTimestamp":1732552668,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日00时37分，Liquidia Corporation股票出现异动，股价大幅上涨5.07%。截至发稿，该股报11.19美元/股，成交量35.2525万股，换手率0.42%，振幅4.13%。Liquidia Corporation股票所在的生物技术行业中，整体涨幅为1.73%。Liquidia Corporation公司简介：Liquidia Corp 是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足未满足的患者需求，目前的重点是肺动脉高压  和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126003748abde3522&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126003748abde3522&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0256863811.USD","LU0208291251.USD","BK4007","LU1989772923.USD","PH","BK4161","LU0417517546.SGD","LQDA","LU0320765489.SGD","LU0256863902.USD","LU0211331839.USD","BK4580","BK4585","LU1989772840.SGD","LU0070302665.USD","BK4588"],"gpt_icon":0},{"id":"1159078559","title":"异动解读 | 生物技术股Liquidia Technologies Inc(LQDA)盘中大涨5.02% 财报数据利好","url":"https://stock-news.laohu8.com/highlight/detail?id=1159078559","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159078559?lang=zh_cn&edition=full","pubTime":"2024-11-23 04:34","pubTimestamp":1732307663,"startTime":"0","endTime":"0","summary":"生物技术公司Liquidia Technologies Inc(LQDA)今日盘中大涨5.02%,引发市场关注。\n\n最新财报数据显示,该公司实现营业收入445万美元,净亏损2316万美元。虽然净利润为负值,但营收数据利好,这或是导致股价上涨的主要原因。\n\n作为一家专注于肺动脉高压及相关疾病治疗领域的生物制药公司,Liquidia Technologies的主打产品为治疗肺动脉高压的吸入粉剂YUTREPIA。公司核心技术PRINT技术可实现精确生产均匀药物颗粒,有望为患者带来更好的治疗方案。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 生物技术股Liquidia Technologies Inc(LQDA)盘中大涨5.02% 财报数据利好","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["LQDA"],"gpt_icon":0},{"id":"2485354219","title":"Liquidia Corporation盘中异动 下午盘股价大涨5.02%报10.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485354219","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485354219?lang=zh_cn&edition=full","pubTime":"2024-11-23 04:24","pubTimestamp":1732307053,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日04时24分，Liquidia Corporation股票出现异动，股价急速拉升5.02%。截至发稿，该股报10.66美元/股，成交量63.1696万股，换手率0.75%，振幅6.21%。Liquidia Corporation股票所在的生物技术行业中，整体涨幅为0.42%。Liquidia Corporation公司简介：Liquidia Corp 是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足未满足的患者需求，目前的重点是肺动脉高压  和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112304241398e443a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112304241398e443a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PH","BK4161","LQDA","BK4585","LU0256863811.USD","BK4007","LU0256863902.USD","LU1989772840.SGD","BK4588","LU0211331839.USD","LU0320765489.SGD","LU1989772923.USD","LU0208291251.USD","BK4580","LU0417517546.SGD","LU0070302665.USD"],"gpt_icon":0},{"id":"2485196394","title":"Liquidia Corporation2024财年第三财季实现净利润-23.16百万美元，同比减少46.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485196394","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485196394?lang=zh_cn&edition=full","pubTime":"2024-11-22 00:00","pubTimestamp":1732204826,"startTime":"0","endTime":"0","summary":"11月22日，Liquidia Corporation公布财报，公告显示公司2024财年第三财季净利润为-23.16百万美元，同比减少46.68%；其中营业收入为4.45百万美元，同比增加20.92%，每股基本收益为-0.30美元。从资产负债表来看，Liquidia Corporation总负债1.42亿美元，其中短期债务1.25百万美元，资产负债比为1.79，流动比率为0.07。机构评级：截至2024年11月22日，当前有9家机构对Liquidia Corporation目标价做出预测，其中目标均价为25.44美元，其中最低目标价为17.00美元，最高目标价为31.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122000040abd50d9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122000040abd50d9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LQDA"],"gpt_icon":0},{"id":"2483386880","title":"Liquidia 公司报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483386880","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483386880?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:25","pubTimestamp":1731511559,"startTime":"0","endTime":"0","summary":"Liquidia 公司报告截至 9 月 30 日的季度业绩 - 收益摘要Liquidia Corp LQDA.OQ报告了截至9月30日的季度调整后每股亏损30美分，低于去年同期的每股收益-24美分。Liquidia Corp 公布的本季度每股收益为亏损 30 美分。该公司当季亏损 2316 万美元。Liquidia Corp 本季度股价上涨了 6.3%，今年迄今为止亏损了 11.6%。华尔街对 Liquidia Corp 的 12 个月目标价中位数为 27.00 美元。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nL4T3MK1MG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LQDA"],"gpt_icon":0},{"id":"2482482303","title":"Liquidia Corp 预计每股亏损37美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482482303","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482482303?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:59","pubTimestamp":1731085164,"startTime":"0","endTime":"0","summary":"Liquidia Corp 预计每股亏损37美分 - 财报前瞻Liquidia Corp LQDA.OQ LQDA.O将于11月13日发布截至2024年9月30日的季度业绩报告，预计该公司的季度收入将有所增长。LSEG 分析师对 Liquidia Corp 的平均预期是每股亏损 37 美分。华尔街对 Liquidia Corp 的 12 个月目标价中位数为 27.00 美元，高于其上次收盘价 10.83 美元。11月8日 - 以往季度业绩。除非另有说明，否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4T3MF26T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"gpt_icon":0},{"id":"2473105068","title":"Liquidia Corporation盘中异动 大幅拉升5.08%报10.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473105068","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473105068?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:37","pubTimestamp":1728308258,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时37分，Liquidia Corporation股票出现异动，股价大幅上涨5.08%。截至发稿，该股报10.54美元/股，成交量15.8867万股，换手率0.19%，振幅4.69%。Liquidia Corporation股票所在的生物技术行业中，整体涨幅为0.15%。Liquidia Corporation公司简介：Liquidia Corp 是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足未满足的患者需求，目前的重点是肺动脉高压  和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072137399719ea1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072137399719ea1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765489.SGD","BK4007","LU0070302665.USD","LU0417517546.SGD","BK4585","LU0256863902.USD","LU1989772923.USD","PH","LQDA","LU0256863811.USD","BK4161","LU0211331839.USD","LU1989772840.SGD","BK4588","BK4580","LU0208291251.USD"],"gpt_icon":0},{"id":"2468504617","title":"Liquidia Corporation盘中异动 早盘股价大涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468504617","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468504617?lang=zh_cn&edition=full","pubTime":"2024-09-19 23:26","pubTimestamp":1726759573,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日23时26分，Liquidia Corporation股票出现异动，股价大幅上涨5.25%。Liquidia Corporation股票所在的生物技术行业中，整体涨幅为1.75%。Liquidia Corporation公司简介：Liquidia Corp 是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足未满足的患者需求，目前的重点是肺动脉高压  和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919232614a1db3625&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919232614a1db3625&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0256863811.USD","PH","LU0070302665.USD","BK4007","LU0208291251.USD","BK4161","LU0211331839.USD","LU0417517546.SGD","LU0256863902.USD","BK4580","BK4588","LQDA","LU0320765489.SGD","LU1989772840.SGD","LU1989772923.USD","BK4585"],"gpt_icon":0},{"id":"2461549381","title":"Liquidia Corporation盘中异动 大幅上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461549381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461549381?lang=zh_cn&edition=full","pubTime":"2024-08-24 02:16","pubTimestamp":1724437018,"startTime":"0","endTime":"0","summary":"北京时间2024年08月24日02时16分，Liquidia Corporation股票出现波动，股价大幅上涨5.00%。Liquidia Corporation股票所在的生物技术行业中，整体涨幅为0.20%。Liquidia Corporation公司简介：Liquidia Corp 是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足未满足的患者需求，目前的重点是肺动脉高压  和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240824021659a1d608bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240824021659a1d608bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765489.SGD","BK4161","LU0256863902.USD","LU0070302665.USD","BK4007","PH","BK4580","LU1989772923.USD","LU0256863811.USD","LQDA","LU1989772840.SGD","LU0211331839.USD","BK4585","LU0208291251.USD","LU0417517546.SGD","BK4588"],"gpt_icon":0},{"id":"2461434815","title":"BUZZ-Liquidia挑战竞争对手吸入式药物的监管排他性后业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2461434815","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461434815?lang=zh_cn&edition=full","pubTime":"2024-08-22 21:56","pubTimestamp":1724335011,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) (更新)    8月22日 - ** Liquidia Corp   股价下跌2.61%，报9.72美元** 该公司称已向美国哥伦比亚特区地方法院提起 (link) 诉讼，对美国食品和药物管理局授予United Therapeutics    竞争对手药物Tyvaso DPI 3年独家经营权的决定提出质疑。** 卫生监管机构周一推迟了对Liquidia公司吸入式药物yutrepia的 (link) 传统批准，只允许暂时批准。** 目前，该药物的最终批准将推迟到 2025 年 5 月 23 日专营权到期之后。** 股价今年以来下跌了约 18","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UTHR","LU1699723380.USD","BK4007","LU1571399168.USD","BK4532","BK4139","BUZZ","LQDA"],"gpt_icon":0},{"id":"2461313416","title":"BUZZ--美国股票走势-Wolfspeed、Synopsys、Zuora","url":"https://stock-news.laohu8.com/highlight/detail?id=2461313416","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461313416?lang=zh_cn&edition=full","pubTime":"2024-08-22 19:50","pubTimestamp":1724327451,"startTime":"0","endTime":"0","summary":"标普500指数小型股  上涨0.22%，报5,653.75点；纳斯达克100指数小型股  上涨0.34%，报19,977点。** Liquidia Corp   ：盘前下跌0.9%BUZZ - 在该公司质疑竞争对手吸入式药物的监管专属性后下跌   ** Synopsys Inc   ：盘前上涨 2.4%BUZZ - 因乐观的第四季度预测和第三季度业绩而上涨   ** Cyclo Therapeutics Inc   ：盘前下跌16.7%BUZZ - 与Rafael Holdings达成合并协议后下跌","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345774631.USD","LU1791807156.HKD","LU0889565833.HKD","LU1989764748.USD","BK4007","LU1815333072.USD","BK4528","LU0690374961.EUR","LU0345774391.USD","SCHW","LU0690374615.EUR","LU0130517989.USD","LU0061474960.USD","SNPS","AAP","SGXZ23171101.USD","LU1989764664.SGD","LU0266013472.USD","SG9999014013.SGD","LU2125909593.SGD","BK4535","BK4094","BK4558","ZUO","BK4097","ZM","LU2404859741.USD","URBN","LU0130102774.USD","CYTH","SG9999014039.USD","BK4559","LU0082616367.USD","SG9999014005.SGD","LU1923623000.USD","LU1988902786.USD","BK4551","BK4585","LU2125909247.SGD","LQDA","BK4116","LU2433249047.HKD","BUZZ","LU0648001328.SGD","LU1951200564.SGD","LU0106831901.USD","LU2404859667.USD","LU1951198990.SGD"],"gpt_icon":1},{"id":"2461243394","title":"BUZZ-Liquidia因竞争对手的吸入式药物在监管部门的独家经营权受到挑战而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2461243394","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461243394?lang=zh_cn&edition=full","pubTime":"2024-08-22 18:41","pubTimestamp":1724323292,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    8月22日 - ** Liquidia公司  股价盘前下跌2.71%，报9.71美元** 该公司称已向美国哥伦比亚特区地方法院提起 (link) 诉讼，质疑FDA授予United Therapeutics    竞争对手药物Tyvaso DPI 3年独家经营权的决定。** 卫生监管机构周一推迟了对Liquidia公司吸入式药物yutrepia的 (link) 传统批准，只允许暂时批准。** 目前，该药的最终批准将推迟到 2025 年 5 月 23 日专营权到期之后。** 截至上一交易日收盘，股价年累计下跌约 17","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UTHR","BK4532","BUZZ","LQDA","BK4139","LU1571399168.USD","BK4007","LU1699723380.USD"],"gpt_icon":0},{"id":"2461391527","title":"更新版 1-Liquidia挑战竞争对手吸入式药物的监管排他性","url":"https://stock-news.laohu8.com/highlight/detail?id=2461391527","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461391527?lang=zh_cn&edition=full","pubTime":"2024-08-22 18:22","pubTimestamp":1724322157,"startTime":"0","endTime":"0","summary":"     路透8月22日 - Liquidia Corp   周四表示，它已对美国食品和药物管理局授予United Therapeutics   治疗肺部疾病的吸入式药物三年专营权的决定提出法律挑战。美国食品和药物管理局周一批准了United Therapeutics公司的Tyvaso DPI的监管专营权，从而推迟了Liquidia公司的吸入式药物yutrepia的传统批准时间。Liquidia 向哥伦比亚特区地方法院提起诉讼。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UTHR","BK4532","LQDA","BK4139","LU1571399168.USD","BK4007","LU1699723380.USD"],"gpt_icon":0},{"id":"2461993383","title":"Liquidia 提起诉讼，质疑竞争对手吸入式药物的监管排他性","url":"https://stock-news.laohu8.com/highlight/detail?id=2461993383","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461993383?lang=zh_cn&edition=full","pubTime":"2024-08-22 18:06","pubTimestamp":1724321205,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透8月22日 - Liquidia Corp   周四表示，该公司已向美国哥伦比亚特区地方法院提起诉讼，对美国食品和药物管理局最近决定授予United Therapeutics的  治疗一种肺部疾病的吸入式药物三年独家经营权一事提出质疑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UTHR","LU1699723380.USD","BK4007","LU1571399168.USD","BK4532","BK4139","LQDA"],"gpt_icon":0},{"id":"2461870011","title":"Liquidia Corporation盘中异动 股价大涨5.00%报10.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461870011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461870011?lang=zh_cn&edition=full","pubTime":"2024-08-22 03:43","pubTimestamp":1724269392,"startTime":"0","endTime":"0","summary":"北京时间2024年08月22日03时43分，Liquidia Corporation股票出现异动，股价急速拉升5.00%。截至发稿，该股报10.08美元/股，成交量208.558万股，换手率2.72%，振幅7.60%。Liquidia Corporation股票所在的生物技术行业中，整体跌幅为0.43%。Liquidia Corporation公司简介：Liquidia Corp 是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足未满足的患者需求，目前的重点是肺动脉高压  和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822034313ab5ee379&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822034313ab5ee379&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4580","BK4588","LU0417517546.SGD","PH","BK4007","LU0320765489.SGD","LU0211331839.USD","LU0256863902.USD","LU0070302665.USD","LU1989772923.USD","LU0208291251.USD","BK4161","BK4585","LU1989772840.SGD","LQDA","LU0256863811.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.liquidia.com","stockEarnings":[{"period":"1week","weight":0.0372},{"period":"1month","weight":0.0742},{"period":"3month","weight":0.1304},{"period":"6month","weight":-0.0714},{"period":"1year","weight":-0.028},{"period":"ytd","weight":-0.049}],"compareEarnings":[{"period":"1week","weight":-0.0198},{"period":"1month","weight":-0.0012},{"period":"3month","weight":0.0411},{"period":"6month","weight":0.0903},{"period":"1year","weight":0.2557},{"period":"ytd","weight":0.2514}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Liquidia Corporation于2020年6月17日在特拉华州成立。该公司是一家生物制药公司，专注于解决未满足患者需求产品的开发、制造和商业化，目前的重点是肺动脉高压的治疗。该公司通过两家全资子公司Liquidia Technologies和Liquidia PAH作为单一实体运营。该公司通过应用心肺疾病方面的专业知识和专有的PRINT技术进行新产品的研究、开发和制造，PRINT技术是一种粒子工程平台，能够精确生产均匀的药物颗粒，旨在提高广泛疗法的安全性、有效性和性能。通过与第三方的产品开发和研究，该公司拥有将PRINT应用于多种给药途径和药物有效载荷的经验，包括吸入疗法、疫苗、生物制剂、核酸和眼科植入物等。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.035484},{"month":2,"riseRate":0.833333,"avgChangeRate":0.087008},{"month":3,"riseRate":0.5,"avgChangeRate":-0.044367},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.075222},{"month":5,"riseRate":0.833333,"avgChangeRate":0.15291},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.059983},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.087113},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.013548},{"month":9,"riseRate":0.428571,"avgChangeRate":0.082402},{"month":10,"riseRate":0.571429,"avgChangeRate":0.019418},{"month":11,"riseRate":0.714286,"avgChangeRate":0.037106},{"month":12,"riseRate":0.571429,"avgChangeRate":0.160266}],"exchange":"NASDAQ","name":"Liquidia Technologies Inc","nameEN":"Liquidia Technologies Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Liquidia Technologies Inc(LQDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Liquidia Technologies Inc(LQDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Liquidia Technologies Inc,LQDA,Liquidia Technologies Inc股票,Liquidia Technologies Inc股票老虎,Liquidia Technologies Inc股票老虎国际,Liquidia Technologies Inc行情,Liquidia Technologies Inc股票行情,Liquidia Technologies Inc股价,Liquidia Technologies Inc股市,Liquidia Technologies Inc股票价格,Liquidia Technologies Inc股票交易,Liquidia Technologies Inc股票购买,Liquidia Technologies Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Liquidia Technologies Inc(LQDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Liquidia Technologies Inc(LQDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}